21 Comments
 
Most Helpful

Exits: MOE/LAZ/PJT > PWP

Comp: PJT/MOE/PWP > LAZ

Overall I would say that MOE and PJT are slightly better than the other two (taking into account overall perception, growth, desirability, etc.), but the difference is so small that it really becomes meaningless (sort of like comparing GS to MS)

 

IMO these are all comparable names more or less. Some hardos might prefer Moelis over the others while people who want a more chill environment will opt for PWP for example

 

Any EB will get you great looks for PE/buyside shops (with obvious outlier groups like PJT RSSG/EVR RX). At a super high level though: Don't go to Moelis if you want to have a life (but you will have stellar exits and get lots of reps in)... EVR RX/M&A obviously stellar all around with top pay... PWP top culture/pay with great exits... PJT M&A is a tier below RSSG but still great exits albeit a sweatshop... LAZ is honestly just questionable now with departures and downtrend in performance... GHL will likely continue going downhill

 

PJT RSSG (consensus no. 1 rx group) > MOE RX (great traction and impressive mandates) > LAZ RX (lost too many seniors) > PWP RX (too small IMO and dealflow is fluctuating AFAIK)

 

What are you talking about?

PWP beat HL this year for Creditor advisory mandates +a couple big time debtor side mandates. PIMCO literally switched advisors from Evercore to PWP for iheart…
 

its more like PJT>PWP/Moelis>> Lazard. We pitched against Lazard (I’m at another EB) and they won the advisory by slashing their fees. Not the best look.

 

curious to know why PWP is considered worse (not working there)? Saw them on some pretty big deals this year and their average deal size is probably higher than Moelis or Lazard

 

How does average deal size matter? Perella has higher average deal size than for eg Moelis yet at my target people would take Moelis 9/10. Perella simply hasn't been consistent enough to really be placed with the other top EBs (CVP, EVR, MOE, and PJT).  

 

Consequatur repudiandae nihil et. Ratione inventore non eos nostrum sit dolor et pariatur. Sint aliquid ducimus est vel exercitationem. Accusantium beatae cupiditate quia inventore. Nisi autem aut qui iste beatae sit voluptatem.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan No 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (15) $434
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
DrApeman's picture
DrApeman
98.9
6
GameTheory's picture
GameTheory
98.9
7
dosk17's picture
dosk17
98.9
8
CompBanker's picture
CompBanker
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”